Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             100 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acetylcholine receptor-specific T lymphocytes in Myasthenia Gravis patients and healthy individuals Sommer, Norbert
1989
2 6 p. 921-922
2 p.
artikel
2 AChR specific T lymphocytes in Myasthenia Gravis Zhang, Yiping
1989
2 6 p. 907-
1 p.
artikel
3 A common anti-DNA antibody idiotype and anti-phospholipid antibodies in sera from patients with schistosomiasis and filariasis with and without nephritis Thomas, Mark A.B.
1989
2 6 p. 803-811
9 p.
artikel
4 Analysis of anti acethylcholinesterase antibodies occurrence in Myasthenia Gravis Margarit, Rita
1989
2 6 p. 929-
1 p.
artikel
5 A new mammalian animal model for experimental autoimmune Myasthenia gravis induced by a mammalian nicotinic acetylcholinereceptor Schreiber, M.
1989
2 6 p. 901-
1 p.
artikel
6 Antibodies against sarcoplasmic reticulum in serum from patients with myasthenia gravis Hofstad, Håkon
1989
2 6 p. 925-926
2 p.
artikel
7 Antibodies to acetylcholine receptors in Myasthenia Gravis. In vitro production by peripheral blood monocytes and thymectomy Kuks, J.B.M.
1989
2 6 p. 927-
1 p.
artikel
8 Anti-filamin antibodies in Myasthenia Gravis Evoli, A.
1989
2 6 p. 924-
1 p.
artikel
9 Anti-Ia treatment modulates specific and polyclonal antibody responses in Trypanosoma cruzi-infected mice Spinella, Sylviane
1989
2 6 p. 791-802
12 p.
artikel
10 Anti-thymus autoantibodies in Myasthenia Gravis Safar, D.
1989
2 6 p. 934-
1 p.
artikel
11 A protein with AchR-like epitopes in MG-associated thymic epithelial tumors and extrathymic neoplasms. Immunohistochemical detection and biochemical characterisation Marx, A
1989
2 6 p. 911-912
2 p.
artikel
12 Are there Ach-receptors in myasthenia-associated thymomas? A molecular genetic analysis Geuder, K.I.
1989
2 6 p. 910-
1 p.
artikel
13 A study of mononuclear cell activation in myasthenia gravis Åhlberg, Richard
1989
2 6 p. 923-
1 p.
artikel
14 Autoantibodies against a nuclear 56 kDa protein: a marker for inflammatory muscle disease Arad-Dann, Hadas
1989
2 6 p. 877-888
12 p.
artikel
15 Auto-antibody repertoir in some autoimmune diseases and in normals Sundewall,
1989
2 6 p. 929-930
2 p.
artikel
16 Azathioprine, steroids and plasmaexchange in M.G. follow-up. Clinical evaluation with a computer assisted protocol Cornelio, F.
1989
2 6 p. 913-
1 p.
artikel
17 B and T cell activation in patients with myasthenia gravis Berrih-Aknin, S.
1989
2 6 p. 931-932
2 p.
artikel
18 Binding of thymopoietin to acetyl-receptor of rat: Study on embryo muscle culture and motor enplate Eymard, B.
1989
2 6 p. 933-
1 p.
artikel
19 Cell-mediated immunity in MG: Delayed skin reactions to AChR in patients with MG Apostolski, Slobodan
1989
2 6 p. 923-924
2 p.
artikel
20 Characterization of the IL-2-receptor on rheumatoid arthritis synovial fluid T cells Dauphinée, Michael J.
1989
2 6 p. 813-824
12 p.
artikel
21 Clinical and biological features of the myasthenias Newsom-Davis, J.
1989
2 6 p. 895-897
3 p.
artikel
22 Clinical scoring in Myasthenia gravis Oosterhuis, H.J.G.H.
1989
2 6 p. 949-950
2 p.
artikel
23 Clinical scoring in Myasthenia gravis Oosterhuis, H.J.G.H.
1989
2 6 p. 949-
1 p.
artikel
24 Clinical scoring systems in myasthenia gravis (MG) Oosterhuis, H.J.G.H.
1989
2 6 p. 944-945
2 p.
artikel
25 CNS involvement in myasthenia gravis Aarli, Johan A.
1989
2 6 p. 934-935
2 p.
artikel
26 Cognitive dysfunction in myasthenia gravis Pampanin, M.
1989
2 6 p. 940-941
2 p.
artikel
27 Comparison of T cell sites recognized by thymic and blood lymphocytes in Myasthenia Gravis patients Berrih-Aknin, S.
1989
2 6 p. 902-903
2 p.
artikel
28 Comparison of the effects of Prednisone versus Azathioprine in the treatment of myasthenia gravis. Preliminary results of a prospective study Gajdos, Ph.
1989
2 6 p. 915-
1 p.
artikel
29 Detection of a human autoantibody against intercalated cells of kidney-collecting tubule Raghunath, Michael
1989
2 6 p. 889-894
6 p.
artikel
30 1,25 Dihydroxyvitamin-D3 regulation of immunoglobulin production in peripheral blood mononuclear cells of patients with Systemic Lupus Erythematosus Chong, Penny J.
1989
2 6 p. 861-867
7 p.
artikel
31 305DRQ HLA-DR/DQ Patterns in different types of Myasthenia Gravis Björn, Carlsson
1989
2 6 p. 898-
1 p.
artikel
32 Early onset Myasthenia Gravis: Report on 59 patients Batocchi, Anna Paola
1989
2 6 p. 936-
1 p.
artikel
33 Effect of different classes of steroids on myogenesis of cultured rat muscle cells Vilquin, Jean-Thomas
1989
2 6 p. 919-
1 p.
artikel
34 Effects of glucocorticoids on myogenesis in vitro Tranchant, Christine
1989
2 6 p. 918-
1 p.
artikel
35 Efficacy of a new immunoadsorbent therapy in myasthenia gravis (MG) treatment Micaglio, GianFranco
1989
2 6 p. 942-943
2 p.
artikel
36 Electrodiagnosis of experimental Myasthenia Gravis Braun, Serge
1989
2 6 p. 916-
1 p.
artikel
37 Epitope Mapping of the human acetylcholine receptor alpha-subunit residues 10 – 84 with myasthenia gravis patient sera Eng, Hubert
1989
2 6 p. 920-
1 p.
artikel
38 Experimental autoimmune Myasthenia Gravis analysed by stimulated single fiber electromyography Verschuuren, Jan JGM
1989
2 6 p. 919-920
2 p.
artikel
39 Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera Sophianos, Demetris
1989
2 6 p. 777-789
13 p.
artikel
40 Further characterization of the MIR by the use of continuously overlapping peptides Papadouli, Irene
1989
2 6 p. 925-
1 p.
artikel
41 HLA antigens and Myasthenia Gravis Fincati, E.
1989
2 6 p. 915-916
2 p.
artikel
42 Humoral immunity in patients with Myasthenia Gravis before and after thymectomy Kuks, J.B.M.
1989
2 6 p. 926-927
2 p.
artikel
43 Hydrophobic binding properties of AChR-antibodies: aspects for therapy and pathomechanism in myasthenia gravis Heininger, K.
1989
2 6 p. 908-
1 p.
artikel
44 IgG class anti-cardiolipin antibody as a possible marker for evaluating fetal risk in patients with systemic lupus erythematosus Shimada, Kaoru
1989
2 6 p. 843-849
7 p.
artikel
45 IgG subclasses and semi-selective plasma perfusion in Myasthenia Gravis Bartoccioni, Emanuela
1989
2 6 p. 935-936
2 p.
artikel
46 IL-1 production in pathological thymi Aime, C.
1989
2 6 p. 931-
1 p.
artikel
47 Immunogenetics of autoimmune disease Steinman, Lawrence
1989
2 6 p. 951-952
2 p.
artikel
48 Immunogenetics, thymic morphology and clinical course of myasthenia gravis Schalke, B.C.G.
1989
2 6 p. 899-
1 p.
artikel
49 Immunoglobulin allotypes in myasthenia gravis (MG) patients with thymoma and non-receptor antibodies Gilhus, Nils Erik
1989
2 6 p. 897-
1 p.
artikel
50 Immunohistochemical evidence for enhanced epidermal growth factor receptor expression in human thymomas Provenzano, Carlo
1989
2 6 p. 933-934
2 p.
artikel
51 Immunoreactivity to foetal acetylcholine receptor disappears during the 33D week of human foetal development and reappears with denervation Hesselmans, L.F.G.M.
1989
2 6 p. 921-
1 p.
artikel
52 Immunostimulation circumvents diabetes in NOD Lt mice Serreze, David V.
1989
2 6 p. 759-776
18 p.
artikel
53 Increased levels of acetylcholine receptor mRNA correlate with experimental autoimmune myasthenia gravis Asher, Orna
1989
2 6 p. 900-
1 p.
artikel
54 Influence of Epstein-Barr virus infection on B lymphocyte responses in patients with rheumatoid arthritis Becker, Heidemarie E.
1989
2 6 p. 825-831
7 p.
artikel
55 Interaction of AChR synthetic peptides with HLA-DR5 molecule Romagnoli, Paola.
1989
2 6 p. 898-899
2 p.
artikel
56 Interaction of anti-DNA antibodies with synthetic polyanionic antigens Weber, Kathryn
1989
2 6 p. 851-859
9 p.
artikel
57 In vitro synthesis of antibodies to acetylcholine receptor by lymphocytes derived from patients with Myasthenia Gravis Brenner, Talma
1989
2 6 p. 907-908
2 p.
artikel
58 In vivo and in vitro studies of facial muscles of “myasthenic” rats Plomp, Jaap J.
1989
2 6 p. 900-901
2 p.
artikel
59 Ion channels in epithelial cells from thymus and thymomas of myasthenia gravis patients Siara, Johann
1989
2 6 p. 912-
1 p.
artikel
60 Isolation and expression of cDNAS for the human muscle nicotinic acetylcholine receptor Beeson, D.
1989
2 6 p. 902-
1 p.
artikel
61 Lems antibody causes reduction of α-conotoxin binding sites in a human neuroblastoma cell line Leys, Katherine
1989
2 6 p. 928-
1 p.
artikel
62 Longitudinal electrophysiological studies of passively transferred Myasthenia Gravis: Searching for an anaesthetic Monaco, Mauro Lo
1989
2 6 p. 917-
1 p.
artikel
63 Long-term results of corticosteroid therapy in Myasthenia Gravis Evoli, Amelia
1989
2 6 p. 914-
1 p.
artikel
64 Lymphoblastoid cell line derived from thymus of human myasthenic Braun, Serge
1989
2 6 p. 932-
1 p.
artikel
65 Methodological aspects in evaluating therapy of myasthenia gravis Gajdos, Ph.
1989
2 6 p. 950-951
2 p.
artikel
66 Mice immunised with recombinant subunit of the human acetylcholine receptor (AChR) develop anti-AChR antibodies but not experimental autoimmune myasthenia gravis (EAMG) Jermy, A.
1989
2 6 p. 903-904
2 p.
artikel
67 Monoclonal and polyclonal anti-acetylcholine receptor antibodies share crossreactive idiotopes Verschuuren, Jan JGM
1989
2 6 p. 906-
1 p.
artikel
68 Mouse T and B cell recognition epitopes on the recombinant human muscle acetylcholine receptor α-subunit Palace, J.
1989
2 6 p. 905-
1 p.
artikel
69 Myasthenia and familial Hodgkin's disease associated in one patient Tranchant, Christine
1989
2 6 p. 948-
1 p.
artikel
70 Myasthenia gravis and myasthenic syndromes in children Špalek, Peter
1989
2 6 p. 947-
1 p.
artikel
71 Myasthenia gravis and pregnancy Muysken, A.
1989
2 6 p. 943-
1 p.
artikel
72 Myasthenia gravis in pregnancy: Two clinical cases Ricciardi, Roberta
1989
2 6 p. 946-
1 p.
artikel
73 Myasthenia Gravis with antireticuline antibodies but without antiacetylcholine-receptor-antibodies: A distinct subtype of myasthenia Hoogenraad, Tj.U.
1989
2 6 p. 926-
1 p.
artikel
74 “Myasthenic” rats show resistance to the chronic toxic effects of neostigmine van Kempen, G.Trudy H.
1989
2 6 p. 948-949
2 p.
artikel
75 Neonatal myasthenia gravis (NMG): Clinical and immunological aspects Eymard, Bruno
1989
2 6 p. 939-940
2 p.
artikel
76 Nuclear imaging and the assessment of human Fc receptor function: Studies in systemic lupus erythematosus Lin, Robert Y.
1989
2 6 p. 833-842
10 p.
artikel
77 Oligoclonal IgG in cerebrospinal fluid of myasthenia gravis patients Nikolie, Jelena
1989
2 6 p. 944-
1 p.
artikel
78 Pharmacological and immunological properties of voltage-operated calcium channels in human neuroblastoma and small-cell lung carcinoma cell lines Sher, E.
1989
2 6 p. 909-
1 p.
artikel
79 Physiopathology of Myasthenia Gravis: Staging of single muscle involvement by EMG study of fatigability and weakness Scoppetta, C.
1989
2 6 p. 946-947
2 p.
artikel
80 Plasma exchange therapy by semiselective adsorption of anti-AChR autoantibodies Knorr-Held, Susanne
1989
2 6 p. 941-942
2 p.
artikel
81 Plasma from anti-AChR Ab negative MG patients reduces Na+ influx into TE671 cells Yamamoto, Takeshi
1989
2 6 p. 930-
1 p.
artikel
82 Preliminary results of an open trial of cyclosporine in nine patients with steroidodependent Myasthenia Gravis Bove, R
1989
2 6 p. 937-938
2 p.
artikel
83 Recent studies on structure and function of the main immunogenic region of the acetylcholine receptor Tzartos, Socrates J.
1989
2 6 p. 905-906
2 p.
artikel
84 Rethymectomy in myasthenia gravis Djukić, Petar
1989
2 6 p. 939-
1 p.
artikel
85 Seronegative autoimmune generalized Myasthenia Gravis Casali, C.
1989
2 6 p. 938-
1 p.
artikel
86 Serum concentrations of IgM, IgG1, IgG2b, IgG3 and IgA in C57BL 6 mice and their congenics at the lpr (lymphoproliferation) locus Klein-Schneegans, Anne-Sophie
1989
2 6 p. 869-875
7 p.
artikel
87 Sleep apneas Myasthenia Gravis Gajdos, Ph.
1989
2 6 p. 941-
1 p.
artikel
88 ‘Spontaneous’ Myasthenia Gravis in a rat after syngeneic bone marrow transplantation Verschuuren, Jan JGM
1989
2 6 p. 909-910
2 p.
artikel
89 Steroid treatment in a case of myasthenia gravis associated with thymoma and immunodeficiency (good's syndrome) Ricciardi, Roberta
1989
2 6 p. 945-
1 p.
artikel
90 Steroid treatment in Myasthenia Gravis: A retrospective two-year study of 144 cases Cosi, V.
1989
2 6 p. 913-914
2 p.
artikel
91 Structural aspects of acetylcholine receptor Fuchs, Sara
1989
2 6 p. 953-
1 p.
artikel
92 Structural aspects of acetylcholine receptor Fuchs, Sara
1989
2 6 p. 952-953
2 p.
artikel
93 T-Cell epitopes in patients with myasthenia gravis defined by the use of recombinant polypeptides of the humanacetylcholine receptor Harcourt, G.
1989
2 6 p. 903-
1 p.
artikel
94 TE671 cell and solubilized human muscle acetylcholine receptors: Similarities and differences in immunological properties Morel, Evelyne
1989
2 6 p. 904-905
2 p.
artikel
95 TE 671 cells: Potential use as a source of muscle type nAChR for studies of myasthenia gravis Ward, Joanna M.
1989
2 6 p. 922-923
2 p.
artikel
96 The influence of single plasma exchange on the neuromuscular transmission in patient with Myasthenia Gravis Bogdanović, Gradimir
1989
2 6 p. 937-
1 p.
artikel
97 The role of AChR in lymphocyte proliferation in patients with myasthenia gravis Lavrnić, Dragana
1989
2 6 p. 927-928
2 p.
artikel
98 The significance of T suppressor cells in the development of autoimmunity Tomer, Yaron
1989
2 6 p. 739-758
20 p.
artikel
99 Transsymaptic adaptation in skeletal muscle of “myasthenic” rats Molenaar, Peter C.
1989
2 6 p. 917-918
2 p.
artikel
100 Well-differentiated thymic carcinoma: A newly defined tumor type showing high association with myasthenia gravis Kirchner, Th.
1989
2 6 p. 911-
1 p.
artikel
                             100 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland